Atlas Trials

Multiple Ascending Dose and Electroencephalography Trial of GATE-202 in Healthy Volunteers

Clinical trial NCT05597241 · COMPLETED

Trial details

NCT number
NCT05597241
Sponsor
Syndeio Biosciences, Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2022-10-15
Primary completion
2023-04-04
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.